Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation
Megakaryocyte-derived mitochondria transplantation offers a promising avenue for treating metabolic disorders, leveraging existing mechanisms. Future research should address limitations in megakaryocyte biogenesis and heterogeneity, and optimize delivery systems to maximize therapeutic efficacy.
Authors
- Éric Boilard (ORCID: https://orcid.org/0000-0001-6319-6432)
- Martin Pelletier (ORCID: https://orcid.org/0000-0001-5033-4947)
- Émilie Mercure
Institutions
- Institut thématique Immunologie, inflammation, infectiologie et microbiologie (FR)
- Centre d'Immunologie et des Maladies Infectieuses (FR)
- Université Laval (CA)
Publication Details
- Journal
- Current Opinion in Hematology
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1097/moh.0000000000000889
- Citations
- 1
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77